GlassScriptPhysician profile
Nijole Glaze
NPI 1356414262
$441.13
in general payments reported to CMS, 2019-2025
11 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $45.99 · 2022: $61.86 · 2023: $18.00 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $187.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $141.51 | 2025 | Repatha |
| Allergan, INC. | $101.82 | 2019-2020 | |
| Abbvie INC. | $70.18 | 2020-2022 | |
| Shield Therapeutics INC | $28.19 | 2025 | |
| Amag Pharmaceuticals, INC. | $20.07 | 2019 | |
| Mylan Pharmaceuticals INC. | $18.84 | 2019 | |
| Mayne Pharma Commercial LLC | $18.52 | 2022 | |
| Exeltis, USA INC. | $18.00 | 2023 | Slynd |
| Roche Diagnostics Corporation | $12.61 | 2019 | |
| Amarin Pharma, INC. | $11.39 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nijole Glaze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.